tiprankstipranks
Trending News
More News >
Adial Pharma (ADIL)
:ADIL
US Market
Advertisement

Adial Pharmaceuticals (ADIL) Financial Statements

Compare
587 Followers

Adial Pharmaceuticals Financial Overview

Adial Pharmaceuticals's market cap is currently $7.26M. The company's EPS TTM is $-0.18; its P/E ratio is ―; Adial Pharmaceuticals is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Adial Pharmaceuticals Debt to Assets

Adial Pharmaceuticals Cash Flow

Adial Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis